An alteration in the signaling pathway of the CaSR has been associated with the development of a variety of tumors including colorectal and breast tumors, where the role of the CaSR has been described as that of a tumor suppressor in the former and that of an oncogene in the latter [3,4]. Here, CASR is linked to neoplasm.